Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
| 07-2025 | 07-2024 | 07-2023 | 07-2022 | 07-2021 | |
| Sales | 2,202 | 1,963 | 1,877 | 1,853 | 3,927 |
| Cost of Goods | 899 | 811 | 906 | 853 | 1,852 |
| Gross Profit | 1,303 | 1,152 | 971 | 1,000 | 2,075 |
| Operating Expenses | 4,474 | 5,154 | 5,820 | 5,577 | 5,238 |
| Operating Income | -2,272 | -3,191 | -3,943 | -3,724 | -2,311 |
| Interest Expense | 299 | 155 | 14 | 6 | 4 |
| Other Income | 172 | -4 | -4 | 239 | -4 |
| Pre-tax Income | -2,399 | -3,350 | -3,961 | -3,491 | -2,319 |
| Net Income Continuous | -2,399 | -3,350 | -3,961 | -3,491 | -2,319 |
| Net Income | $-2,399 | $-3,350 | $-3,961 | $-3,491 | $-2,319 |
| EPS Basic Total Ops | -0.02 | -0.03 | -0.04 | -0.04 | -0.03 |
| EPS Basic Continuous Ops | -0.02 | -0.03 | -0.04 | -0.04 | -0.03 |
| EPS Diluted Total Ops | -0.02 | -0.03 | -0.04 | -0.04 | -0.03 |
| EPS Diluted Continuous Ops | -0.02 | -0.03 | -0.04 | -0.04 | -0.03 |
| EPS Diluted Before Non-Recurring Items | -0.02 | -0.03 | -0.04 | -0.04 | -0.03 |
| EBITDA(a) | $-2,270 | $-3,043 | $-3,826 | $-3,511 | $-2,139 |